A conclusion could be drawn that PGRN and ANG have common regulatory functions in the progression of neurodegenerative diseases, and tsRNAs are promising candidates that deserve further evaluation as non‐invasive clinical biomarkers. This evidence concerns the gene GRN and neurodegenerative disease.